[go: up one dir, main page]

TW200626170A - Vaccine for periodontal disease - Google Patents

Vaccine for periodontal disease

Info

Publication number
TW200626170A
TW200626170A TW094102336A TW94102336A TW200626170A TW 200626170 A TW200626170 A TW 200626170A TW 094102336 A TW094102336 A TW 094102336A TW 94102336 A TW94102336 A TW 94102336A TW 200626170 A TW200626170 A TW 200626170A
Authority
TW
Taiwan
Prior art keywords
periodontal disease
vaccine
kits
detecting
treating
Prior art date
Application number
TW094102336A
Other languages
English (en)
Inventor
Kimberly Jean Dreier
John Morgan Hardham
Rajendra Krishnan
David Ross Mcgavin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TW200626170A publication Critical patent/TW200626170A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6879—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for sex determination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW094102336A 2003-10-23 2005-01-26 Vaccine for periodontal disease TW200626170A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51372403P 2003-10-23 2003-10-23

Publications (1)

Publication Number Publication Date
TW200626170A true TW200626170A (en) 2006-08-01

Family

ID=34520129

Family Applications (5)

Application Number Title Priority Date Filing Date
TW093132010A TW200517495A (en) 2003-10-23 2004-10-21 Vaccine for periodontal disease
TW094102336A TW200626170A (en) 2003-10-23 2005-01-26 Vaccine for periodontal disease
TW097115456A TW200848508A (en) 2003-10-23 2005-04-26 Vaccine for periodontal disease
TW094113297A TW200637572A (en) 2003-10-23 2005-04-26 Vaccine for periodontal disease
TW097115457A TW200902055A (en) 2003-10-23 2005-04-26 Vaccine for periodontal disease

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW093132010A TW200517495A (en) 2003-10-23 2004-10-21 Vaccine for periodontal disease

Family Applications After (3)

Application Number Title Priority Date Filing Date
TW097115456A TW200848508A (en) 2003-10-23 2005-04-26 Vaccine for periodontal disease
TW094113297A TW200637572A (en) 2003-10-23 2005-04-26 Vaccine for periodontal disease
TW097115457A TW200902055A (en) 2003-10-23 2005-04-26 Vaccine for periodontal disease

Country Status (17)

Country Link
US (1) US20060257429A1 (zh)
EP (1) EP1678294A1 (zh)
JP (1) JP2007508837A (zh)
KR (1) KR20060064690A (zh)
CN (1) CN1918281A (zh)
AR (1) AR046554A1 (zh)
AU (1) AU2004284298A1 (zh)
BR (1) BRPI0415742A (zh)
CA (1) CA2542221A1 (zh)
CO (1) CO5680493A2 (zh)
IL (1) IL174699A0 (zh)
MX (1) MXPA06004537A (zh)
NO (1) NO20062147L (zh)
RU (1) RU2006113588A (zh)
TW (5) TW200517495A (zh)
WO (1) WO2005040359A1 (zh)
ZA (1) ZA200602414B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008137506A2 (en) * 2007-05-01 2008-11-13 Mars Incorporated Methods and kits for dog plaque disease

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) * 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) * 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) * 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) * 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) * 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) * 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) * 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) * 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) * 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) * 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) * 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) * 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) * 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) * 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
DE69828507T2 (de) * 1997-05-20 2006-01-05 Galenica Pharmaceuticals, Inc. Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkung
US6153210A (en) * 1997-08-14 2000-11-28 Periodontix, Inc. Use of locally delivered metal ions for treatment of periodontal disease
US7468185B2 (en) * 2001-12-21 2008-12-23 Pfizer Inc. Vaccine for periodontal disease

Also Published As

Publication number Publication date
CA2542221A1 (en) 2005-05-06
TW200517495A (en) 2005-06-01
AU2004284298A1 (en) 2005-05-06
BRPI0415742A (pt) 2006-12-19
KR20060064690A (ko) 2006-06-13
EP1678294A1 (en) 2006-07-12
RU2006113588A (ru) 2006-08-10
TW200637572A (en) 2006-11-01
TW200902055A (en) 2009-01-16
TW200848508A (en) 2008-12-16
NO20062147L (no) 2006-07-21
AR046554A1 (es) 2005-12-14
IL174699A0 (en) 2006-08-20
WO2005040359A1 (en) 2005-05-06
CO5680493A2 (es) 2006-09-29
US20060257429A1 (en) 2006-11-16
ZA200602414B (en) 2007-08-29
JP2007508837A (ja) 2007-04-12
MXPA06004537A (es) 2006-06-23
CN1918281A (zh) 2007-02-21

Similar Documents

Publication Publication Date Title
WO2003054755A3 (en) Vaccine for periodontal disease
ATE474585T1 (de) Probiotische enterokokken für eine verbesserte immunität
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
MXPA05009352A (es) Metodos y composiciones para tratamiento y prevencion de staphylococcus y otras infecciones bacterianas.
MXPA03000809A (es) Polimero de polisiloxano, procedimiento para su preparacion y su uso.
WO2008041966A3 (en) Broad spectrum antibacterial compounds
ZA200604412B (en) Bacterial virulence factors and uses thereof
WO2004104175A3 (en) Probiotic bacteria and methods
NO20065064L (no) Vaksine for tannsykdommer
MX2007007291A (es) Procedimiento de produccion eficiente novedoso para polisacaridos capsulares de bacterias gram positivas patogenas mediante expresion heterologa y secrecion de polisacaridos complejos en bacterias gram positivas no patogenas, no invasivas.
IL190601A0 (en) Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
WO2006128089A3 (en) Compositions and methods for treating tissue
TW200637572A (en) Vaccine for periodontal disease
FR2904557B1 (fr) Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques
DE602005015329D1 (de) Rutheniumkomplexe zur krebsbehandlung
ATE318933T1 (de) Nukleinsäurefragmente zur identifizierung von dechlorierenden bakterien
DE602005020915D1 (de) Mannose-spezifische adhesinen und deren vervendung
MY148252A (en) 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines
WO2001000877A3 (en) Method of isolation of regulated virulence determinants from bacterial pathogens
GB0423126D0 (en) Protein
WO2001051649A3 (en) Identification of virulence determinants
TW200608986A (en) Bioprotective agent
GB0228691D0 (en) Bacterial virulence genes
DE602004031127D1 (de) Attenuierte bakterielle lebendvakzine
WO2007108903A3 (en) Campylobacter vaccines and methods of use